Why Inovio Stock Is Rising Today
Shares of Inovio Pharmaceuticals (NASDAQ: INO) were rising 5.4% as of 12:06 p.m. EST on Wednesday. The gain came after the company provided its third-quarter update following the market close on Tuesday. Inovio's biggest news was that the U.S. Food and Drug Administration (FDA) has given the go-ahead for the initiation of a phase 3 study of COVID-19 vaccine INO-4800.
Inovio's planned U.S. phase 3 study of INO-4800 had been held up due to the FDA's partial clinical hold. However, that hold has now been lifted after the agency reviewed additional non-clinical, clinical, and device information supplied by the company.
Image source: Getty Images.
Source Fool.com